Product Name :
Reference Brand :
Case Dimentions (inches) :
Bottle Size(inches) :
Product Shelf Life :
blue colored, 7 mm round,biconvex, film coated tablets
marked F5 on one side and plain on other side.
Therapeutic Class :
Indications for Use :
1.1 MonotherapyFinasteride Tablets, USP are indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to: Improve symptoms Reduce the risk of the need for surgery including transurethral resection of the prostate (TURP) and prostatectomy. 1.2 Combination with Alpha-Blocker Finasteride Tablets, USP administered in combination with the alpha-blocker doxazosin is indicated to reduce the risk of symptomatic progression of BPH (a confirmed = 4 point increase in American Urological Association (AUA) symptom score).
Inactive Ingrediant :
Film coating: Opadry Y-1-7000H White (hypromellose, USP; titanium dioxide, USP; polyethylene glycol 400, NF)